VYN-24142-33957 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-14
Dose 1 — Pfizer-BioNTech
2021-04-05
Dose 2 — Pfizer-BioNTech
2021-04-06
Registered in v-safe
2021-04-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-06
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-04-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-26
Survey response — day 21, dose 2
MedDRA: Fatigue, Pain, Pyrexia — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Low grade temp (100.2), exhaustion, body aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-07
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-14	Pfizer-BioNTech
2	2021-04-05	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-04-06	priority 2/3

Free text

Release 8 — day 21, dose 2

2021-04-26

Symptoms: Low grade temp (100.2), exhaustion, body aches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Pyrexia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release